BOIRON : Activity in 2017

BOIRON : Activity in 2017

(Unaudited data)

in thousands of euros
2016
2017
Variation at current exchange rates
Variation at constant exchange rates


France
370,870
378,487
+2.1%
+2.1%


Europe (excluding France)
163,849
155,151
-5.3%
-7.3%


North America
64,916
68,572
+5.6%
+7.4%


Other countries
14,854
15,330
+3.2%
+1.5%


Group total
614,489
617,540
+0.5%
+0.1%

in thousands of euros
2016
2017
Variation at current exchange rates
Variation at constant exchange rates


Non-proprietary Homeopathic Medicines
313,365
310,594
-0.9%
-0.8%


OTC Specialties
299,672
305,552
+2.0%
+1.1%


Other
1 452
1 394
-4.0%
-4.1%


Group total
614,489
617,540
+0.5%
+0.1%

in thousands of euros
1st quarter
2nd quarter
3rd quarter
4th quarter


2016
2017
Var. 17/16
2016
2017
Var. 17/16
2016
2017
Var. 17/16
2016
2017
Var. 17/16


France
90,494
97,134
+7.3%
80,469
79,328
-1.4%
98,840
101,423
+2.6%
101,067
100,602
-0.5%


Europe (excluding France)
43,685
40,418
-7.5%
31,572
27,421
-13.1%
41,273
42,319
+2.5%
47,319
44,993
-4.9%


North America
16,064
18,179
+13.2%
14,113
14,465
+2.5%
16,020
16,055
+0.2%
18,719
19,873
+6.2%


Other countries
3,846
4,532
+17.8%
4,061
3,191
-21.4%
3,280
4,126
+25.8%
3,667
3,481
-5.1%


Group total
154,089
160,263
+4.0%
130,215
124,405
-4.5%
159,413
163,923
+2.8%
170,772
168,949
-1.1%

in thousands of euros
1st quarter
2nd quarter
3rd quarter
4th quarter


2016
2017
Var. 17/16
2016
2017
Var. 17/16
2016
2017
Var. 17/16
2016
2017
Var. 17/16


Non-proprietary Homeopathic Medicines
80,147
81,016
+1.1%
76,001
74,567
-1.9%
73,913
74,350
+0.6%
83,304
80,661
-3.2%


OTC Specialties
73,743
78,968
+7.1%
53,719
49,391
-8.1%
85,319
89,342
+4.7%
86,891
87,851
+1.1%


Other
199
279
+40.2%
495
447
-9.7%
181
231
+27.6%
577
437
-24.3%


Group total
154,089
160,263
+4.0%
130,215
124,405
-4.5%
159,413
163,923
+2.8%
170,772
168,949
-1.1%

HIGHLIGHTS OF THE FOURTH QUARTER

Sales revenue of the fourth quarter 2017 decreased by 1.1% (-0.4% at constant exchange rates). Sales of non-proprietary homeopathic medicines were down by 3.2%. Sales of OTC specialties were up by 1.1%, with a decrease of 13.3% in Russia and an increase of 2.3% in France and 13.2% in the USA.

Annual sales revenue amounted €617,540 thousand and was stable in comparison to 2016 (+0.5% at current exchange rates and +0.1% at constant exchange rates).

The operating income of 2017 should be lower than in 2016.

Our company carries on the development of homeopathy in the world with the same determination.

Our next update: March 14, 2018, after the close of the stock market, publication of 2017 results.

Person responsible for financial information: Christian Boiron

Contact for financial information: Véronique Bouscayrol

Investor relations: +33 (0) 4.78.45.63.43 - e-mail: boironfinances@boiron.fr

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at: www.boironfinance.com

Source: Actusnews